University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents

Coley, HM, Shotton, CF, Ajose-Adeogun, A, Modjtahedi, H and Thomas, H (2006) Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents BIOCHEMICAL PHARMACOLOGY, 72 (8). pp. 941-948.

Full text not available from this repository.
Item Type: Article
Authors :
NameEmailORCID
Coley, HMh.coley@surrey.ac.ukUNSPECIFIED
Shotton, CFUNSPECIFIEDUNSPECIFIED
Ajose-Adeogun, AUNSPECIFIEDUNSPECIFIED
Modjtahedi, HUNSPECIFIEDUNSPECIFIED
Thomas, HUNSPECIFIEDUNSPECIFIED
Date : 16 October 2006
Identification Number : https://doi.org/10.1016/j.bcp.2006.07.022
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Pharmacology & Pharmacy, PHARMACOLOGY & PHARMACY, receptor tyrosine kinase inhibition, ovarian cancer, EGFR expressing, drug resistance, EPIDERMAL-GROWTH-FACTOR, CARCINOMA, CHEMOTHERAPY, ACTIVATION, ANTIBODIES, MUTATIONS, GEFITINIB, SURVIVAL, ALPHA, ACTS
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 08:56
Last Modified : 17 May 2017 14:38
URI: http://epubs.surrey.ac.uk/id/eprint/821559

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800